Taiwan has one of the most progressive healthcare systems in the world and is a major hub for clinical research in the Asia-Pacific region. Currently, it is well positioned to meet the growing demands of the global clinical trial market. Why choose Taiwan There are many good reasons to go to Taiwan for clinical trials. […]

Read More →

Investigators, from Brazil and specialized in Allergy and Immunology segment, are invited to participate in feasibility of a new phase II clinical trial.     What’s this trial about? It’s a phase II – dose selection and confirmatory – clinical trial planned to be conducted in Brazil.   What kind of patients are required for this […]

Read More →